Bioresorbable Medical Material Market Scope And Analysis

  • Report Code : TIPRE00008231
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Bioresorbable Medical Material Market Analysis, Size, and Growth (2023-2031)

Buy Now

Bioresorbable Medical Material Market Report Bioresorbable Medical Material Market Size and Share Bioresorbable Medical Material Market Scope and Analysis

Bioresorbable Medical Material Market Report Scope

Report Attribute Details
Market size in 2022 US$ 1.23 Billion
Market Size by 2031 US$ 2.84 Billion
Global CAGR (2023 - 2031) 9.70 %
Historical Data 2021-2022
Forecast period 2023-2031
Segments Covered By Product Type
  • Polylactide
  • Poly-L-lactide
  • Poly-DL-lactide
  • Polyglycolide
  • Polycaprolactone
By Application
  • Drug Delivery
  • Medical Devices
  • Orthopedics
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Evonik
  • Foster Corporation
  • Poly med Corporation
  • Ashland
  • DSM
  • Corbion
  • Putnam Plastics
  • Zeus Industrial Products Inc

    • Bioresorbable Medical Material Market News and Recent Developments

    The Bioresorbable Medical Material Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for Bioresorbable Medical Material:

    • BD, a leading global medical technology company, acquired Tepha, Inc., a leading developer and manufacturer of proprietary resorbable polymer technology. (Source: BD, Press Release/Company Website/Newsletter, July 2021)
    • Evonik has acquired German biotech company JeNaCell. The acquisition expands Evonik’s biomaterials portfolio to provide biotechnologically derived cellulose. The nature-identical material developed by JeNaCell is used in medical technology and dermatology for the treatment of wounds and burns as well as in hydroactive skin care (Source: Evonik, Press Release/Company Website/Newsletter, Aug 2021)
    • Collagen Matrix, Inc. ("Collagen Matrix"), a global leader in regenerative medicine and a Linden Capital Partners ("Linden") portfolio company, today announced the acquisition of Polyganics, B.V ("Polyganics").  Polyganics is a medical technology company that develops and manufactures bioresorbable medical devices. The acquisition expands Collagen Matrix's portfolio of bioresorbable solutions and technology platforms for bone and tissue repair, unlocking new markets and clinical opportunities for the Company.  (Source: Collagen Matrix, Inc., Press Release/Company Website/Newsletter, Oct 2022)

    Bioresorbable Medical Material Market Report Coverage and Deliverables

    The “Bioresorbable Medical Material Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles